Akili Announces Leadership Transition
Digital Health Global
OCTOBER 6, 2023
The leadership transition follows the company’s announcement in September that it plans to shift from a prescription to a non-prescription business model. Matt excels at advancing both of these value drivers in innovative models and was the spearhead of our recent business model shift. Food and Drug Administration for its indications.
Let's personalize your content